Current concepts in the management of fungal peritonitis

Current Infectious Disease Reports

Volumn 5, Issue 2, 2003, Pages 120-124

  Salvaggio, Michelle R ^a   Pappas, Peter G ^b  

^a University of Alabama at Birmingham   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CASPOFUNGIN; CORTICOSTEROID DERIVATIVE; FLUCONAZOLE; FLUCYTOSINE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; NYSTATIN; PLACEBO; VORICONAZOLE;

ANASTOMOSIS LEAKAGE; CANDIDA; CLINICAL TRIAL; COCCIDIOIDES IMMITIS; CRYPTOCOCCUS; DIGESTIVE SYSTEM PERFORATION; DRUG EFFICACY; DRUG SAFETY; GASTROINTESTINAL SURGERY; GEOTRICHUM CANDIDUM; HOSPITAL INFECTION; HUMAN; INCIDENCE; MYCOSIS; NONHUMAN; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONITIS; REVIEW; RHODOTORULA; TRICHOSPORON;

EID: 2642547646     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-003-0047-1     Document Type: Review

References (38)

1. Laroche M, Harding G: Primary and secondary peritonitis: an update. Eur J Clin Microbiol Infect Dis 1998, 17:542-550.
2. Such J, Runyon BA: Spontaneous bacterial peritonitis. Clin Infec Dis 1998, 27:669-674.
3. Bayer AS, Blumenkrantz MJ, Montgomerie JZ, et al.: Candida peritonitis: report of 22 cases and review of the English literature. Am J Med 1976, 61:832-840.
4. Solomkin J, Flohr A, Quie PC, Simmons RL: The role of Candida in intraperitoneal infections. Surgery 1980, 88:524-530.
5. Alden SM, Frank E, Flanccbaum L: Abdominal candidiasis in surgical patients. Am Surg 1989, 55:45-49.
6. Calandra T, Bille J, Schneider R, et al.: Clinical significance of Candida isolated from peritoneum in surgical patients. Lancet 1989, 2:1437-1440.
7. Eggimann P, Francioli P, Bille J, et al.: Fluconzazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999, 27: 1066-1072.
8. Vas S, Oreopoulos DG: Infections in patients undergoing peritoneal dialysis. Infect Dis Clin North Am 2001, 15:743-774
9. Minnaganti VR, Cunha BA: Infections associated with uremia and dialysis. Infect Dis Clin North Am 2001, 15:385-406.
10. Peterson PK, Matzke G, Keane WF: Current concepts in the management of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Rev Infect Dis 1987, 8:604-612.
11. Chan TM, Chan CY, Cheng SW, et al.: Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: A series of 21 patients. Nephrol Dial Transplant 1994, 9:539-542.
12. Michel C, Courdavault L, Al Khayat R, et al.: Fungal peritonitis in patients on peritoneal dialysis. Am J Nephrol 1994, 14:113-120.
13. Goldie SJ, Kleman-Troidle L, Torres C, et al.: Fungal peritonitis in a large chronic peritoneal dialysis population: A report of 55 patients. Am J Kidney Dis 1996, 28:86-91.
14. Bren A: Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1998, 17:839-843.
15. Wang AYM, Yu AXY, Lam PKT, et al.: Factors predicting outcome of fungal peritonitis in peritoneal dialysis: Analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis 2000, 36:1183-1192.
16. Lopes JO, Alves SH, Klock C, et al.: Trichosporon inkin peritonitis during continuous ambulatory peritoneal dialysis with bibliography review. Mycopathology 1997, 139:15-18.
17. Ujhelyi MR, Raasch RH, van der Horst CM, Mattern WD: Treatment of peritonitis due to Curvularia and Trichosporon with amphotericin B. Rev Infect Dis 1990, 12:621-627.
18. DeVault GA, Brown ST, King JW, et al.: Tenckhoff catheter obstruction resulting from invasion by Curvularia lunata in the absence of peritonitis. Am J Kidney Dis 1985, 6:124-127.
19. Holley JL, Bernardini J, Piraino B: Polymicrobial peritonitis in patients on continuous peritoneal dialysis. Am J Kidney Dis 1992, 19:162-166.
20. Kim GC, Korbet SM: Polymicrobial peritonitis in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 2000, 36:1000-1008.
21. Dressler R, Peters AT, Lynn RI: Pseudomonal and candidal peritonitis as a complication of continuous ambulatory peritoneal dialysis in human immunodeficiency virus-infected patients. Am J Med 1989, 86:787-790.
22. Tebben JA, Rigsby MO, Selwyn PA, et al.: Outcome of HIV infected patients on continous ambulatory peritoneal dialysis. Kidney Int 1993, 23:191-198.
23. Mabee CL, Mabee SW, Kirkpatrick RB, Koletar SL: Cirrhosis: A risk factor for cryptococcal peritonitis. Am J Gastroenterol 1995, 90:2042-2045.
24. Stiefel P, Pamies E, Miranda ML, et al.: Cryptococcal peritonitis: Report of a case and review of the literature. Hepato-Gastroenterol 1999, 46:1618-1622.
25. Spindel SJ, Lacke CE, Pellegrino CR, et al.: Noncandidal fungal peritonitis in patients with AIDS: Report of three cases and review. Clin Infect Dis 1997, 24:279-280.
26. Rex JH, Walsh TJ, Sobel JD, et al.: Practice guidelines for the treatment of Candidiasis. Clin Infect Dis 2000, 30:662-678.
27. Eisenberg ES, Leviton I, Soeiro R: Fungal peritonitis in patients receiving peritoneal dialysis: Experience with 11 patients and review of the literature. Rev Infect Dis 1986, 8:309-321.
28. Keane WF, Bailie GR, Boeschoten E, et al.: Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Peritoneal Dial Int 2000, 20:396-411.
29. Ahmad S, Johnson RJ, Hillier S, et al.: Fungal peritonitis caused by Lecythophora mutabilis. J Clin Microibol 1985, 22:182-186.
30. Prewitt K, Lockard J, Rodgers D, Hasbargen J: Successful treatment of Aspergillus peritonitis complicating peritoneal dialysis. Am J Kidney Dis 1989, 13:501-503.
31. Branton MH, Johnson SC, Brooke JD, Hasbargen JA: Peritonitis due to Rhizopus in a patient undergoing continuous peritoneal dialysis. Rev Infect Dis 1991, 13:19-21.
32. Qadir MT, Cunha BA: Penicillium peritonitis in a patient receiving continuous ambulatory peritoneal dialysis. Heart Lung 1998, 27:67-68.
33. Zaruba K, Peters J, Jungbluth H: Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years' experience. Am J Kidney Dis 1991, 17:43-46.
34. Mora-Duarte J, Betts R, Rotstein C, et al.: Caspofungin vs amphotericin B deoxycholate in the treatment of invasive candidiasis in neutropenic and non-neutropenic patients: a multi-center, randomized, double-blind study. Paper presented at 12th European Congress of Clinical Microbiology and Infectious Diseases. Milan, Italy. April 24-27, 2002.
35. Lo W-K, Chan C-Y, Cheng S-W, et al.: A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1996, 28:549-552.
36. Thodis E, Vas SI, Bargman JM, et al.: Nystatin prophylaxis: Its inability to prevent fungal peritonitis in patients on continous ambulatory peritoneal dialysis. Peritoneal Dial Int 1998, 18:583-589.
37. Williams PF, Moncrieff N, Marriott J: No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Peritoneal Dial Int 2000, 20:342-343.
38. Piraino B: Peritonitis as a complication of peritoneal dialysis. J Am Soc Nephrol 1998, 9:1956-1964.